Segment and Related Information (Tables)

12 Months Ended

Jun. 30, 2015

Schedule of Segment Performance Based on Income (Loss) before Interest Income and Other Income and Expense

The accounting policies of the segments are the same as those described in the summary of significant accounting policies (Note 1). The Company evaluates segment performance based on income (loss) before interest income and other income and expense.

	Diagnostics		Other			Total
Year ended June 30, 2015:
Revenues	$	695.5	$	27.6		$	723.1
Depreciation and amortization		20.5		4.5			25.0
Segment operating income (loss)		217.1		(82.9	)		134.2
Year ended June 30, 2014:
Revenues	$	748.2	$	30.0		$	778.2
Depreciation and amortization		9.9		3.9			13.8
Segment operating income (loss)		338.0		(63.6	)		274.4
Year ended June 30, 2013:
Revenues	$	582.4	$	30.8		$	613.2
Depreciation and amortization		5.0		3.9			8.9
Segment operating income (loss)		291.5		(63.5	)		228.0

	Years Ended June 30,
	2015		2014			2013
Total operating income for reportable segments	$	134.2	$	274.4		$	228.0
Unallocated amounts:
Interest income		0.4		5.4			5.5
Other		0.3		(2.0	)		(0.2	)
Income from operations before income taxes		134.9		277.8			233.3
Income tax provision		54.7		101.6			86.1
Net income	$	80.2	$	176.2		$	147.2

Schedule of Significant Revenues from Major Products by Operating Segment

The following table indicates significant revenues from major products by operating segment:

	Years Ended June 30,						Change						% of Total Revenue
	2015		2014		2013		2015			2014			2015			2014			2013
Diagnostic revenues:
myRisk	$	320.7	$	53.7	$	—	$	267.0		$	53.7			44	%		7	%		N/A
BRACAnalysis		237.6		517.9		460.3		(280.3	)		57.6			33	%		67	%		75	%
VectraDA		43.7		14.0		—		29.7			14.0			6	%		2	%		N/A
Other		93.5		162.6		122.1		(69.1	)		40.5			13	%		21	%		20	%
Total diagnostic revenue		695.5		748.2		582.4		(52.7	)		165.8			96	%		96	%		95	%
Other		27.6		30.0		30.8		(2.4	)		(0.8	)		4	%		4	%		5	%
Total revenue	$	723.1	$	778.2	$	613.2	$	(55.1	)	$	165.0			100	%		100	%		100	%

Schedule Of Comparison of Balance Sheet Assets by Operating Segment

The following table sets forth a comparison of balance sheet assets by operating segment:

	June 30,
	2015		2014
Net equipment, leasehold improvements and property:
Diagnostics		34.5		24.3
Other		32.7		10.3
Total	$	67.2	$	34.6
Total Assets:
Diagnostics		450.6		409.9
Other		130.2		143.4
Total	$	580.8	$	553.3

Reconciliation of Assets by Operating Segment to Total Assets

The following table reconciles assets by operating segment to total assets:

	June 30,
	2015		2014
Total assets by segment	$	580.8	$	553.3
Cash, cash equivalents, and marketable investment securities (1)		185.4		270.5
Total	$	766.2	$	823.8

(1) The Company manages cash, cash equivalents, and marketable investment securities at the consolidated level for all segments